Sign in Sign up for free

Akari Therapeutics Plc Short % of float

What is the Short % of float of Akari Therapeutics Plc?

The Short % of float of Akari Therapeutics Plc is 0.00%

What is the definition of Short % of float?



Short percentage of float is the amount of shares being shorted compared to the float expressed as a percentage.

= short interest / float shares

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Short % of float of companies in the Health Care sector on NASDAQ compared to Akari Therapeutics Plc

What does Akari Therapeutics Plc do?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Companies with short % of float similar to Akari Therapeutics Plc